ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell resolution.

Nektar Therapeutics sees its stock nearly double after announcing positive Phase IIb data for its lead pipeline candidate, rezpegaldesleukin (rezpeg), in atopic dermatitis (AD).

Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.

The AI model, Pleiades, accurately diagnoses early-stage neurodegenerative disease by using noninvasive blood tests to analyze the epigenome.